Filing Details
- Accession Number:
- 0001562180-22-004174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-18 08:34:58
- Reporting Period:
- 2022-05-16
- Accepted Time:
- 2022-05-18 08:34:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1822791 | Clene Inc. | CLNN | Pharmaceutical Preparations (2834) | 852828339 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1835428 | Robert Glanzman | 6550 South Millrock Drive Suite G50 Salt Lake City UT 84121 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-05-16 | 4,717 | $2.03 | 10,564 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman.
Billionaire Hedge Funds
